Personal
Information
Yunlong Hou, Harbin Medical University, Associate Professor.
Research
Fields
Cardiovascular Pharmacology, Drug research
& Development
Work
Experience
10.2011- Present Associate
Professor, Harbin Medical University
10.2011 Instructor, Harbin Medical University
07.2011 Harbin Medical University, Ph.D. in
Pharmacology
07.2008 Harbin Medical University, M.S. in
Pharmacology
05.2007 Visiting Scholar, Sanwa Kagaku Kenkyusho
Co., Ltd., Japan
03.2005 Assistant researcher, Harbin Medical University
07.2001 Harbin Medical University,B.S. in
Clinical Medicine
Paper
Submission
-
Kato, N., Y. Hou, et al. (2009).
Kallidinogenase normalizes retinal vasopermeability in
streptozotocin-induced diabetic rats: potential roles ofvascular endothelial
growth factor and nitric oxide. Eur J Pharmacol 606(1-3), 187-190
-
Hou, Y., S. Fan, et al. (2010).
Pharmacokinetic study of mangiferin in rat plasma and retina using
high-performance liquid chromatography. Mol Vis 16: 1659-1668
-
Tang, J. S., Y. L. Hou, et al. (2011).
Polyphenols from Parabarium huaitingii and their positive inotropic and
anti-myocardial infarction effectsin rats. Phytomedicine 18(7): 544-550
-
Zhu, J., R. Xie, et al. (2012).
Homocysteine enhances clot-promoting activity of endothelial cells via
phosphatidylserine externalization andmicroparticles formation. Amino Acids
43(3): 1243-1250
-
Yang, Y., X. Piao, et al. (2012).
Bioactivity-guided fractionation of the triglyceride-lowering component
and in vivo and in vitro evaluation ofhypolipidemic effects of Calyx seu
Fructus Physalis. Lipids Health Dis 11:38
-
Hou, Y., Y. Sun, et al. (2012).
Beta-adrenoceptor regulates miRNA expression in rat heart. Med Sci Monit
18(8): BR309-314